Clinical Trials Directory

Trials / Completed

CompletedNCT02812563

Familial Analysis of Keratoconus Risk

Status
Completed
Phase
Study type
Observational
Enrollment
95 (actual)
Sponsor
University Hospital, Bordeaux · Academic / Other
Sex
All
Age
7 Years
Healthy volunteers
Accepted

Summary

The principal objective of this study is to evaluate the frequency of KC inside family of patients with confirmed KC. It's a familial, epidemiological, prospective, single-center study.

Detailed description

Keratoconus is a common bilateral progressive corneal ectatic disease causing visual impairment by inducing irregular astigmatism and corneal opacities. This disorder typically begins during teenage years, progresses until the age of 30 to 40 years and, in severe forms, may need a corneal transplantation. Currently, keratoconus has not known etiopathogenesis, and it is difficult to detect subclinical forms. Several risk factors seem to be implied, environmental and genetic : the risk of keratoconus in case of familial history of keratoconus isn't well known at that time, but seems to be important to consider to promote screening and follow up of patient with a familial history of keratoconus (KC).

Conditions

Interventions

TypeNameDescription
OTHERgeneticGalilee exam - Corn analysis with Optiwave Refractive Analysis

Timeline

Start date
2014-11-25
Primary completion
2017-09-19
Completion
2017-09-19
First posted
2016-06-24
Last updated
2017-11-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02812563. Inclusion in this directory is not an endorsement.

Familial Analysis of Keratoconus Risk (NCT02812563) · Clinical Trials Directory